EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Androgen actions in metabolic tissues in polycystic ovary syndrome

Caitlin L MacRae iD, Rebecca E Campbell iD

Endocrinology · 2026

DOI: 10.1210/endocr/bqag001 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endocrinology, 2026. Verfasst von Caitlin L MacRae und 1 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Neuroendocrinology and Department of Physiology, Faculty of Biomedical Sciences, University of Otago, Dunedin 9054, New Zealand. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Androgens. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Health Research Council of New Zealand.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polycystic ovary syndrome (PCOS) is a common reproductive disorder characterized by irregular ovulation, cyst-like follicles on the ovaries, and hyperandrogenism. PCOS is also strongly associated with increased risk of obesity and metabolic diseases such as type 2 diabetes and metabolic dysfunction-associated steatotic liver disease (MASLD). Hyperandrogenism independently associates with many of the metabolic symptoms observed in women with PCOS, and increased androgen signaling in the female brain is hypothesized to impair central homeostatic mechanisms controlling food intake and body weight. However, peripheral metabolic organs such as pancreas, liver, fat, and skeletal muscle all express the androgen receptor, suggesting that direct androgen signaling in these organs may disrupt peripheral metabolic health. Although it is difficult to separate the impacts of hyperandrogenism from hyperinsulinemia and insulin resistance, tissue explant studies and transgenic knockout models provide the ability to interrogate signaling through the androgen receptor in metabolic organs. This review will summarize and discuss recent evidence implicating hyperandrogenism as a driver of metabolic impairments in PCOS, with an emphasis on the molecular mechanisms by which androgens may alter metabolic function in the periphery in females.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeAndrogensHumansFemaleAnimalsHyperandrogenismReceptors, AndrogenSignal TransductionLiver

Stichwörter der Autor:innen

PCOSadipose tissueandrogen receptorhyperandrogenismliver

Substanzen

AndrogensReceptors, Androgen

Autor:innen und Institutionen

  • Centre for Neuroendocrinology and Department of Physiology, Faculty of Biomedical Sciences, University of Otago, Dunedin 9054, New Zealand.

ORCID-Profile: Caitlin L MacRae, Rebecca E Campbell

Förderung

  • Health Research Council of New Zealand

Zitieren

APA

MacRae, C. L., & Campbell, R. E. (2026). Androgen actions in metabolic tissues in polycystic ovary syndrome. Endocrinology. https://doi.org/10.1210/endocr/bqag001

Vancouver

MacRae CL, Campbell RE. Androgen actions in metabolic tissues in polycystic ovary syndrome. Endocrinology. 2026. doi:10.1210/endocr/bqag001

BibTeX
@article{MacRae2026,
  author = {MacRae, Caitlin L and Campbell, Rebecca E},
  title = {Androgen actions in metabolic tissues in polycystic ovary syndrome},
  journal = {Endocrinology},
  year = {2026},
  doi = {10.1210/endocr/bqag001}
}
Kostenlos starten →